THYROGLOBULIN (TG) - ANVISA Registration 80189860293

Access comprehensive regulatory information for THYROGLOBULIN (TG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80189860293 and manufactured by RPC DIAGNOSTIC SYSTEMS. The registration is held by ANFLA PRODUTOS PARA DIAGNOSTICOS LABORATORIAL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80189860293
Registration Details
ANVISA Registration Number: 80189860293
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

DS EIA ANTI-TIREOGLOBULINA (TG)
Risk Class II

Registration Details

80189860293

25351363215201599

05774798000142

Company Information

Russia
PT: RÚSSIA (FEDERAÇÃO RUSSA)

Dates and Status

Aug 31, 2015

VIGENTE

09/18/2025 19:00:01